Do you remember Sputnik V? The anti corona vaccine developed in Russia and used by Russia, which was ready August 2020, so months before Western vaccines entered the market? Where many thought it's just a piece of Russian propaganda, nothing more, due to lack of studies and discarded it entirely as useless trash?
Well there is now peer reviewed study by the EMA, and they do show an amazing efficiency of 91.6% after the first dose, they also do consider it safe to use. The study has been published in the Lancet. Sputnik V uses a vector virus, just like AstraZeneca. AstraZeneca though has only an efficiency of around 70%. This is good news for Africa and such, because Sputnik V can be kept cold using a normal refrigerator compared to other vaccines, which do require much more cooling.
Basically Sputnik V was created using the same methods used by AstraZeneca, but a little bit more clever: dose 1 uses a different virus than dose 2 does, and this is done on purpose.
Also known as Gam-COVID-Vac, the vaccine uses a heterologous recombinant adenovirus approach using adenovirus 26 (Ad26) and adenovirus 5 (Ad5) as vectors for the expression of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) spike protein. The use of two varying serotypes, which are given 21 days apart, is intended to overcome any pre-existing adenovirus immunity in the population. Among the major COVID vaccines in development to date, only Gam-COVID-Vac uses this approach; others, such as the Oxford–AstraZeneca vaccine, use the same material for both doses.
Denis Logunov and colleagues1 report their interim results from a phase 3 trial of the Sputnik V COVID-19 vaccine in The Lancet. The trial results show a consistent strong protective effect across all participant age groups. Also known as Gam-COVID-Vac, the vaccine uses a heterologous...
www.thelancet.com